These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4835142)

  • 1. Neonatal screening for phenylketonuria. IV. Factors influencing the occurrence of false positives.
    Holtzman NA; Meek AG; Mellits ED
    Am J Public Health; 1974 Aug; 64(8):775-9. PubMed ID: 4835142
    [No Abstract]   [Full Text] [Related]  

  • 2. Neonatal screening for phenylketonuria. II. Age dependence of initial phenylalanine in infants with PKU.
    Holtzman NA; Mellits ED; Kallman CH
    Pediatrics; 1974 Mar; 53(3):353-7. PubMed ID: 4815254
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of phenylalanine-to-tyrosine ratio determined by tandem mass spectrometry to improve newborn screening for phenylketonuria of early discharge specimens collected in the first 24 hours.
    Chace DH; Sherwin JE; Hillman SL; Lorey F; Cunningham GC
    Clin Chem; 1998 Dec; 44(12):2405-9. PubMed ID: 9836704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The advantage of phenylalanine to tyrosine ratio for the early detection of phenylketonuria.
    Levy PA; Miller JB; Shapira E
    Clin Chim Acta; 1998 Feb; 270(2):177-81. PubMed ID: 9544454
    [No Abstract]   [Full Text] [Related]  

  • 5. Neonatal screening for phenylketonuria. I. Effectiveness.
    Holtzman NA; Meek AG; Mellits ED
    JAMA; 1974 Aug; 229(6):667-70. PubMed ID: 4408320
    [No Abstract]   [Full Text] [Related]  

  • 6. [Phenylketonuria screening: false-positive and false-negative results].
    Clemens P; Plettner C; Grüttner R
    Dtsch Med Wochenschr; 1983 Apr; 108(16):627-8. PubMed ID: 6839986
    [No Abstract]   [Full Text] [Related]  

  • 7. [The traps of Guthrie's test].
    Saudubray JM; Charpentier C
    Arch Fr Pediatr; 1976 Nov; 33(G):915-20. PubMed ID: 827271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPLC for confirmatory diagnosis and biochemical monitoring of Cuban patients with hyperphenylalaninemias.
    Contreras J; Alonso E; Fuentes LE
    MEDICC Rev; 2015 Jan; 17(1):23-8. PubMed ID: 25725765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylalanine and other amino acids in phenylketonuria.
    Clemens PC; Burmester JG; Prankel BH; Wiegand G; Wulke AP; Plettner C
    J Inherit Metab Dis; 1993; 16(6):1045-6. PubMed ID: 8127057
    [No Abstract]   [Full Text] [Related]  

  • 10. Large-scale investigation of 2 phenylketonuria screening methods and factors affecting blood phenylalanine levels in the newborn.
    Holton JB
    Arch Dis Child; 1973 Feb; 48(2):161. PubMed ID: 4690518
    [No Abstract]   [Full Text] [Related]  

  • 11. An enzymatic assay of plasma phenylalanine and tyrosine for the detection and management of phenylketonuria.
    Shen RS; Richardson CJ; Rouse BM; Abell CW
    Biochem Med; 1981 Oct; 26(2):211-21. PubMed ID: 7317039
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of transient hyperphenylalaninemia and tyrosinemia in low birth weight Negro infants fed high protein diets.
    Watkins ML; Crump EP; Hara S
    J Natl Med Assoc; 1971 Jul; 63(4):241-5. PubMed ID: 4946844
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma phenylalanine and tyrosine levels during the day in normal female controls and female obligate phenylketonuria heterozygotes.
    De Groot CJ; Hommes FA
    Enzyme; 1982; 28(4):404-7. PubMed ID: 7151779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Guthrie screening test for phenylketonuria: a report on two years participation in the national programme.
    Becroft DM; Horn CR
    N Z Med J; 1969 Apr; 69(443):212-5. PubMed ID: 5254295
    [No Abstract]   [Full Text] [Related]  

  • 15. False positive result of Guthrie inhibition assay for histidinaemia in a patient with phenylketonuria.
    Sakura N; Kawahara N; Tanabe M; Miura T; Kanamori K; Yoshino A; Ohtake H
    J Inherit Metab Dis; 1990; 13(2):234-5. PubMed ID: 2116557
    [No Abstract]   [Full Text] [Related]  

  • 16. Fifteen-year experience with screening for phenylketonuria with an automated fluorometric method.
    Kirkman HN; Carroll CL; Moore EG; Matheson MS
    Am J Hum Genet; 1982 Sep; 34(5):743-52. PubMed ID: 7124729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn phenylalanine/tyrosine metabolism. Implications for screening for phenylketonuria.
    Schneider AJ
    Am J Dis Child; 1983 May; 137(5):427-32. PubMed ID: 6846269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular concentrations of phenylalanine, tyrosine and alpha-aminobutyric acid in 13 homozygotes and 19 heterozygotes for phenylketonuria compared with 26 normals.
    Thalhammer O; Pollak A; Lubec G; Königshofer H
    J Inherit Metab Dis; 1981; 4(2):73-4. PubMed ID: 6790854
    [No Abstract]   [Full Text] [Related]  

  • 19. Neonatal screening for phenylketonuria. 3. Altered sex ratio; extent and possible causes.
    Holtzman NA; Meek AG; Mellits ED; Kallman CH
    J Pediatr; 1974 Aug; 85(2):175-81. PubMed ID: 4842793
    [No Abstract]   [Full Text] [Related]  

  • 20. Intracellular concentrations of phenylalanine, tyrosine and alpha-aminobutyric acid in 13 homozygotes and 19 heterozygotes for phenylketonuria (PKU) compared with 26 normals.
    Thalhammer O; Pollak A; Lubec G; Königshofer H
    Hum Genet; 1980; 54(2):213-6. PubMed ID: 7390492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.